These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9372921)

  • 21. The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence.
    Tiley LS; Madore SJ; Malim MH; Cullen BR
    Genes Dev; 1992 Nov; 6(11):2077-87. PubMed ID: 1427073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transactivation of heterologous promoters by HIV-1 tat.
    Han P; Brown R; Barsoum J
    Nucleic Acids Res; 1991 Dec; 19(25):7225-9. PubMed ID: 1662814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling the Function of TATA Box Binding Protein in Transcriptional Changes Induced by HIV-1 Tat in Innate Immune Cells and the Effect of Methamphetamine Exposure.
    Tjitro R; Campbell LA; Basova L; Johnson J; Najera JA; Lindsey A; Marcondes MCG
    Front Immunol; 2018; 9():3110. PubMed ID: 30778358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.
    Liu X; Miller CW; Koeffler PH; Berk AJ
    Mol Cell Biol; 1993 Jun; 13(6):3291-300. PubMed ID: 8497252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visna virus Tat protein: a potent transcription factor with both activator and suppressor domains.
    Carruth LM; Hardwick JM; Morse BA; Clements JE
    J Virol; 1994 Oct; 68(10):6137-46. PubMed ID: 8083955
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal components of the transcription apparatus (RNA polymerase II, TATA-binding protein) contain activation domains: is the repetitive C-terminal domain (CTD) of RNA polymerase II a "portable enhancer domain"?
    Seipel K; Georgiev O; Gerber HP; Schaffner W
    Mol Reprod Dev; 1994 Oct; 39(2):215-25. PubMed ID: 7826625
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Wild-type and transactivation-defective mutants of human immunodeficiency virus type 1 Tat protein bind human TATA-binding protein in vitro.
    Wang Z; Morris GF; Rice AP; Xiong W; Morris CB
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):128-38. PubMed ID: 8680883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The human immunodeficiency virus type 1 Vpr transactivator: cooperation with promoter-bound activator domains and binding to TFIIB.
    Agostini I; Navarro JM; Rey F; Bouhamdan M; Spire B; Vigne R; Sire J
    J Mol Biol; 1996 Sep; 261(5):599-606. PubMed ID: 8800208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective use of TBP and TFIIB revealed by a TATA-TBP-TFIIB array with altered specificity.
    Tansey WP; Herr W
    Science; 1997 Feb; 275(5301):829-31. PubMed ID: 9012349
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial zinc finger fusions targeting Sp1-binding sites and the trans-activator-responsive element potently repress transcription and replication of HIV-1.
    Kim YS; Kim JM; Jung DL; Kang JE; Lee S; Kim JS; Seol W; Shin HC; Kwon HS; Van Lint C; Hernandez N; Hur MW
    J Biol Chem; 2005 Jun; 280(22):21545-52. PubMed ID: 15743774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The carboxy-terminal transcription enhancement region of the human spumaretrovirus transactivator contains discrete determinants of the activator function.
    Venkatesh LK; Chinnadurai G
    J Virol; 1993 Jul; 67(7):3868-76. PubMed ID: 8389909
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TATA-binding protein and the Gal4 transactivator do not bind to promoters cooperatively.
    Xie Y; Sun L; Kodadek T
    J Biol Chem; 2000 Dec; 275(52):40797-803. PubMed ID: 11006288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription.
    Bieniasz PD; Grdina TA; Bogerd HP; Cullen BR
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7791-6. PubMed ID: 10393900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure.
    Ham J; Steger G; Yaniv M
    EMBO J; 1994 Jan; 13(1):147-57. PubMed ID: 8306958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of TFIID and USA components in transcriptional activation of the human immunodeficiency virus promoter by NF-kappaB and Sp1.
    Guermah M; Malik S; Roeder RG
    Mol Cell Biol; 1998 Jun; 18(6):3234-44. PubMed ID: 9584164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of Sp1 phosphorylation and NF-kappa B-independent HIV promoter domain activity in T lymphocytes stimulated by okadaic acid.
    Vlach J; Garcia A; Jacqué JM; Rodriguez MS; Michelson S; Virelizier JL
    Virology; 1995 Apr; 208(2):753-61. PubMed ID: 7747447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein.
    Sadovsky Y; Webb P; Lopez G; Baxter JD; Fitzpatrick PM; Gizang-Ginsberg E; Cavailles V; Parker MG; Kushner PJ
    Mol Cell Biol; 1995 Mar; 15(3):1554-63. PubMed ID: 7862148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.